HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deployment of a New CRRT/PIRRT Device during the COVID-19 Pandemic Emergency: Organizational Challenges and Implementation Results.

AbstractINTRODUCTION:
The coronavirus disease 2019 (COVID-19) pandemic led to increased demand nationwide for dialysis equipment, including supplies and machines. To meet the demand in our institution, our surge plan included rapid mobilization of a novel continuous renal replacement treatment (CRRT) machine named SAMI. The SAMI is a push-pull filtration enhanced dialysis machine that can conjugate extremely high single-pass solute removal efficiency with very precise fluid balance control.
MATERIAL AND METHODS:
Machine assembly was conducted on-site by local biomedical engineers with remote assistance by the vendor. One 3-h virtual training session of 3 dialysis nurses was conducted before SAMI deployment. The SAMI was deployed in prolonged intermittent replacement therapy (PIRRT) mode to maximize patients covered per machine per day. Live on-demand vendor support was provided to troubleshoot any issues for the first few cases. After 4 weeks of the SAMI implementation, data on treatments with the SAMI were collected, and a questionnaire was provided to the nurse trainees to assess device usability.
RESULTS:
On-site installation of the SAMI was accomplished with remote assistance. Delivery of remote training was successfully achieved. 23 PIRRT treatments were conducted in 10 patients. 7/10 of patients had CO-VID-19. The median PIRRT dose was 50 mL/kg/h (IQR [interquartile range] 44 - 62 mL/kg/h), and duration of the treatment was 8 h (IQR 6.3 - 8 h). Solute control was adequate. The user response was favorable to the set of usability questions involving user interface, on-screen instructions, machine setup, troubleshooting, and the ease of moving the machine.
CONCLUSION:
Assembly of the SAMI and training of nurses remotely are possible when access to vendor employees is restricted during states of emergency. The successful deployment of the SAMI in our institution during the pandemic with only 3-h virtual training supports that operating the SAMI is simple and safe.
AuthorsLenar T Yessayan, Michael Heung, Francine A Girard, Salma Shaikhouni, Balazs Szamosfalvi
JournalBlood purification (Blood Purif) Vol. 50 Issue 3 Pg. 390-398 ( 2021) ISSN: 1421-9735 [Electronic] Switzerland
PMID33171460 (Publication Type: Journal Article)
Copyright© 2020 S. Karger AG, Basel.
Chemical References
  • Anticoagulants
  • Dialysis Solutions
  • Medical Waste Disposal
  • Heparin
Topics
  • Acute Kidney Injury (blood, etiology, therapy)
  • Anticoagulants (administration & dosage)
  • Attitude of Health Personnel
  • COVID-19 (complications)
  • Continuous Renal Replacement Therapy (instrumentation, methods, nursing)
  • Data Collection
  • Dialysis Solutions (administration & dosage)
  • Disposable Equipment
  • Education, Nursing, Continuing
  • Equipment Design
  • Equipment Failure
  • Hemodialysis Units, Hospital (organization & administration)
  • Heparin (administration & dosage)
  • Humans
  • Intermittent Renal Replacement Therapy (instrumentation, methods, nursing)
  • Maintenance and Engineering, Hospital (organization & administration)
  • Medical Waste Disposal
  • Pandemics
  • Prescriptions
  • Robotics
  • SARS-CoV-2
  • Surveys and Questionnaires
  • Virtual Reality

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: